We found that, while the systemic administration of IGF-Trap alone did not alter tumor progression relative to vehicle-injected mice, the addition of rTMS prior to IGF-Trap injection delayed tumor growth in the treated mice for up to 22 days following glioma cell injection (Figure 5A). This evidence concerns the gene IGF1 and neoplasm.